Investigational Drug Service, University of North Carolina Hospitals — Chapel Hill, North Carolina

Investigational Drug Service, University of North Carolina Hospitals is a clinical research site located in Chapel Hill, North Carolina, United States 27514.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Drug Service, University of North Carolina Hospitals has participated in 1 clinical trials.

Therapeutic areas: Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Drug Service, University of North Carolina Hospitals?

Investigational Drug Service, University of North Carolina Hospitals has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Drug Service, University of North Carolina Hospitals conducted?

Investigational Drug Service, University of North Carolina Hospitals has 1 clinical trials on record. Their work covers Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis.

Is Investigational Drug Service, University of North Carolina Hospitals accredited by Crixeo Health?

Investigational Drug Service, University of North Carolina Hospitals has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Drug Service, University of North Carolina Hospitals?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.